サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1537045

ハイスループットプロセス開発市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

High Throughput Process Development Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 259 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ハイスループットプロセス開発市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年08月13日
発行: Persistence Market Research
ページ情報: 英文 259 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界のハイスループットプロセス開発市場に関する詳細な調査レポートを発行し、市場促進要因・動向・機会・課題などの市場動向に関する詳細な洞察を提供しています。本レポートは、市場構造と将来展望を徹底的に理解することを目的としています。

主要な洞察

  • ハイスループットプロセス開発の世界市場価値（2024年）：108億米ドル
  • 推定市場価値（2033年）：228億米ドル
  • 世界市場成長率（CAGR 2024-2033）：8.70%

ハイスループットプロセス開発の世界市場- レポート範囲：

ハイスループットプロセス開発市場には、主に小型化・自動化されたバイオリアクターの使用を通じて、バイオ医薬品の開発を合理化するための高度な技術や手法の使用が含まれます。これらの技術革新は、細胞培養プロセスを加速させ、医薬品開発と試験の効率を向上させることを目的としています。

市場成長の促進要因：

小型バイオリアクターの活用によるハイスループットプロセス開発

小型バイオリアクターの採用と商業化が、市場の成長を大きく後押ししています。これらのバイオリアクターは、従来のバイオリアクターシステムに比べて、必要な時間やリソースの削減など、数多くの利点を提供します。使い捨ての小型バイオリアクターやマイクロプラットフォームが開発されたことで、新規医薬品の開発や試験におけるこれらのツールに対する需要が高まっています。

高スループットの小型バイオリアクターシステムは、細胞培養プロセスの構築を迅速化し、バイオ医薬品の開発を加速します。例えば、アドバンスト・マイクロスケール・バイオリアクターは、微小なシングルユース・バイオリアクターを含む、大量自動化マイクロ・バイオリアクター・システムです。

バイオテクノロジー応用の拡大

バイオテクノロジー分野における継続的な研究開発は、バイオテクノロジーツールの応用分野を拡大しています。これは、斬新で画期的な技術の導入につながっています。技術と手順の進歩は、多くの雇用機会を創出し、関連する労働力の賃金構造を高めると予想されます。いくつかの国、特に新興経済国の政府は、バイオテクノロジー産業の成長に注力しています。

政府の取り組みと支援

米国では、州政府のさまざまなイニシアチブがバイオサイエンス部門を支援しています。コネチカット州中小企業革新・多角化プログラム、フロリダ州ハイテク回廊フェーズⅡSBIR/STTR外部投資などのプログラムは、中小企業革新研究（SBIR）に資金を提供し支援しています。さらに、米国のバイオテクノロジー産業機構（BIO）は、バイオサイエンス・クラスターを創出するために、ビジネス関係者、学術機関、州政府間の協力を奨励しています。

市場の課題：

より適切な産業モデルの必要性

ハイスループットプロセス開発の将来は、バイオ製造業界内の課題や限界によって影響を受ける可能性があります。GEヘルスケア、ザルトリウスAG、サーモフィッシャーなどの企業は、バイオ製造プロセスを強化するために、より優れた業界関連モデルを提唱しています。

コンピュータ化されたものであれ、縮小されたものであれ、業界モデルを適用することは、商業的製造スケールにおいて重大な課題をもたらします。等価カラム容積と吸着等温モデルパラメーターの見積もりは困難であり、カラム実験における一貫性のないデータと不正確な予測につながる可能性があります。バイオ製造におけるQuality by Designアプローチに対する規制要件の厳格化も、適切なプロセス開発のために、より正確な力学モデルを必要とします。

資格のある専門家の不足

市場拡大を制限しかねない重大な問題は、資格のある専門家の不足です。バイオ製造プロセスで必要とされる複数の並行培養を実施できる熟練した専門家は限られています。学術・研究機関における有能な人材の不足と、新興国におけるCRO（研究開発受託機関）の減少が、ハイスループットプロセス開発市場を制約すると予想されます。

レポートが回答する主な質問

  • 世界のハイスループットプロセス開発市場の成長を促進する主な要因は何か？
  • ハイスループットプロセス開発技術の採用を主導している消費者層は？
  • バイオリアクター技術の進歩は競合情勢にどのような影響を与えているか？
  • ハイスループット・プロセス開発の世界市場における主なプレーヤーは誰か、また彼らは市場ポジションを維持するためにどのような戦略をとっているのか？
  • 世界のハイスループットプロセス開発市場の新興動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品の採用/使用状況分析
  • 製品のUSP/特徴
  • 最近の製品承認と発売
  • PESTLE分析
  • ポーターの分析
  • 規制シナリオ

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • ダイナミクス

第6章 COVID-19危機- 影響評価

  • COVID-19と影響分析
  • 2023年の市場シナリオ

第7章 世界市場の需要（金額または規模）分析

  • 市場（金額）分析、2019～2023年
  • 市場（金額）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • ツールとシステム
      • 手動ツール
      • 自動化ツール
      • 分析ツール
        • HPLC
        • UPLS
        • 質量分析計（MS）
        • ガスクロマトグラフィー（GC）
        • その他
      • 高スループット統合バイオリアクターシステム
        • 使い捨てバイオリアクター
        • 従来のバイオリアクター
    • 消耗品
      • ミニチュア再パックコラム
      • マイクロタイタープレート
      • マイクロピペットとピペットチップ
      • 電極
      • 試薬キットと化学薬品
    • ソフトウェア
    • ソリューションとサービス
  • 製品別市場の魅力分析

第9章 アプリケーション別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 哺乳類細胞培養と微生物発酵
    • プロセス開発と最適化
    • その他
  • アプリケーション別の市場の魅力分析

第10章 プロセス開発別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 上流プロセス
    • 下流プロセス
  • プロセス開発別世界市場の魅力分析

第11章 エンドユーザー別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • バイオ医薬品
    • 契約研究・製造組織
    • 学術研究機関
    • その他
  • エンドユーザー別市場の魅力分析

第12章 地域別：世界市場分析

  • イントロダクション
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 南アジア市場分析

第17章 東アジア市場分析

第18章 オセアニア市場分析

第19章 中東・アフリカ市場分析

第20章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • GE Healthcare
    • Merck KgAa
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • Bio Rad Laboratories Inc.
    • Sartorius AG
    • Agilent Technologies
    • Luminex Applikon
    • Tecan Trading AG
    • Eppendorf AG
    • PerkinElmer Inc.

第22章 使用される前提条件と頭字語

第23章 調査手法

目次
Product Code: PMRREP31236

Persistence Market Research has recently published an in-depth report on the global high throughput process development market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a thorough understanding of the market structure and future outlook.

Key Insights:

  • Global High Throughput Process Development Market Value (2024): US$ 10.8 Billion
  • Estimated Market Value (2033): US$ 22.8 Billion
  • Global Market Growth Rate (CAGR 2024-2033): 8.70%

Global High Throughput Process Development Market - Report Scope:

The high throughput process development market involves the use of advanced technologies and methods to streamline the development of biopharmaceuticals, primarily through the use of miniaturized and automated bioreactors. These innovations are designed to accelerate cell culture processes and improve the efficiency of pharmaceutical development and testing.

Market Growth Drivers:

Utilizing Miniature Bioreactors to Develop High-Throughput Processes

The adoption and commercialization of miniaturized bioreactors are significantly driving market growth. These bioreactors offer numerous advantages over traditional bioreactor systems, such as reduced time and resource requirements. The development of disposable, miniature bioreactors and micro platforms has increased demand for these tools in the development and testing of novel pharmaceutical products.

High throughput miniaturized bioreactor systems expedite the creation of cell culture processes, thus accelerating the development of biopharmaceuticals. For instance, Advanced Microscale Bioreactors are high-volume, automated micro bioreactor systems that include tiny, single-use bioreactors.

Expansion of Biotechnology Applications

Ongoing research and development in the biotechnology sector are expanding the application fields for biotechnology tools. This is leading to the introduction of novel and groundbreaking technologies. The advancements in technology and procedures are expected to create numerous job opportunities and increase the wage structure for the relevant workforce. Governments in several countries, particularly emerging economies, are focusing on the growth of the biotechnology industry.

Government Initiatives and Support

Various state government initiatives in the United States support the bioscience sector. Programs like the Connecticut Small Business Innovation and Diversification Program, Florida High Tech Corridor Phase II SBIR/STTR External Investment, and others provide funding and support for small business innovation research (SBIR). Additionally, the Biotechnology Industry Organization (BIO) in the U.S. encourages collaborations among business stakeholders, academic institutions, and state governments to create bioscience clusters.

Market Challenges:

Need for Better, More Relevant Industry Models

The future of high throughput process development may be impacted by challenges and limitations within the biomanufacturing industry. Companies like GE Healthcare, Sartorius AG, and Thermo Fischer advocate for better industry-relevant models to enhance the biomanufacturing process.

Applying industry models, whether computerized or scaled-down versions, poses significant challenges at the commercial manufacturing scale. Estimating equivalent column volumes and adsorption isotherm model parameters can be difficult, leading to inconsistent data and inaccurate predictions in column experiments. Stricter regulatory requirements for the Quality by Design approach in biomanufacturing also necessitate more accurate mechanistic models for proper process development.

Lack of Qualified Specialists

A significant issue that could limit market expansion is the shortage of qualified specialists. There are limited skilled professionals available to conduct the multiple parallel cultivations required during the bioproduction process. The lack of competent individuals at academic and research institutions and the decline in the number of CROs (Contract Research Organizations) in developing countries are expected to constrain the market for high throughput process development.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global high throughput process development market?
  • Which consumer segments are leading the adoption of high throughput process development technologies?
  • How are advancements in bioreactor technology influencing the competitive landscape?
  • Who are the key players in the global high throughput process development market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global high throughput process development market?

Competitive Intelligence and Business Strategy:

Leading players in the global high throughput process development market, such as GE Healthcare, Sartorius AG, and Thermo Fischer Scientific, focus on innovation, strategic partnerships, and marketing excellence to gain a competitive advantage. These companies invest heavily in R&D to develop advanced and unique high throughput process development tools and expand their product lines. Collaborations with biopharmaceutical companies, research institutions, and technology providers enhance market credibility and support the development of innovative process development solutions. Additionally, leveraging digital marketing and influencer partnerships strengthens market positioning and consumer engagement.

Key Companies Profiled:

  • GE Healthcare
  • Merck KgAa
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Bio Rad Laboratories Inc.
  • Sartorius AG
  • Agilent Technologies
  • Luminex Applikon
  • Tecan Trading AG
  • Eppendorf AG
  • PerkinElmer Inc.

Key Segments Covered in High Throughput Process Development Industry Research

By Product:

  • Tools & Systems
  • Consumables
  • Software
  • Solutions & Services

By Application:

  • Mammalian Cell Culture & Microbial Fermentation
  • Process Development & Optimization
  • Others

By Process Development:

  • Upstream Process
  • Downstream Process

By End User:

  • Biopharmaceuticals
  • Contract Research & Manufacturing Organizations
  • Academic & Research Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Regulatory Scenario

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Life Science Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rise In Government Initiatives To Boost The Global Biotechnology Industry
    • 5.2.2. Adoption Of Miniaturized Bioreactors For High Throughput Process Development
    • 5.2.3. Increase In Research & Development Initiatives
    • 5.2.4. Growth Of The Top Companies
    • 5.2.5. Cost Of The Products
    • 5.2.6. Product And Stock Availability
    • 5.2.7. Mergers And Acquisitions
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Application
    • 6.1.3. By Process Development
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. Tools & Systems
      • 8.3.1.1. Manual Tools
      • 8.3.1.2. Automated Tools
      • 8.3.1.3. Analytical Tools
        • 8.3.1.3.1. HPLC
        • 8.3.1.3.2. UPLS
        • 8.3.1.3.3. Mass Spectrometer (MS)
        • 8.3.1.3.4. Gas Chromatography (GC)
        • 8.3.1.3.5. Others
      • 8.3.1.4. High Throughput Integrated Bioreactor Systems
        • 8.3.1.4.1. Disposable/Single-use Bioreactors
        • 8.3.1.4.2. Conventional Bioreactors
    • 8.3.2. Consumables
      • 8.3.2.1. Miniature Repacked Columns
      • 8.3.2.2. Microtiter Plates
      • 8.3.2.3. Micropipettes and Pipette Tips
      • 8.3.2.4. Electrodes
      • 8.3.2.5. Reagent Kits & Chemicals
    • 8.3.3. Software
    • 8.3.4. Solutions & Services
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 9.3.1. Mammalian Cell Culture & Microbial Fermentation
    • 9.3.2. Process Development & Optimization
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Process Development

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By Process Development, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Process Development, 2024-2033
    • 10.3.1. Upstream Process
    • 10.3.2. Downstream Process
  • 10.4. Market Attractiveness Analysis By Process Development

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Biopharmaceuticals
    • 11.3.2. Contract Research & Manufacturing Organizations
    • 11.3.3. Academic & Research Institutes
    • 11.3.4. Others
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Process Development
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By Process Development
    • 13.4.5. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. U.S. Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Product
        • 13.5.1.2.2. By Application
        • 13.5.1.2.3. By Process Development
        • 13.5.1.2.4. By End User
    • 13.5.2. Canada Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Product
        • 13.5.2.2.2. By Application
        • 13.5.2.2.3. By Process Development
        • 13.5.2.2.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Application
    • 14.3.3. By Process Development
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By Process Development
    • 14.4.5. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Brazil Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By Application
        • 14.5.1.2.3. By Process Development
        • 14.5.1.2.4. By End User
    • 14.5.2. Mexico Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By Application
        • 14.5.2.2.3. By Process Development
        • 14.5.2.2.4. By End User
    • 14.5.3. Argentina Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Product
        • 14.5.3.2.2. By Application
        • 14.5.3.2.3. By Process Development
        • 14.5.3.2.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. France
      • 15.3.1.3. Italy
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. Russia
      • 15.3.1.7. BENELUX
      • 15.3.1.8. Nordic Countries
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By Process Development
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
    • 15.4.4. By Process Development
    • 15.4.5. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. Germany Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By Application
        • 15.5.1.2.3. By Process Development
        • 15.5.1.2.4. By End User
    • 15.5.2. France Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By Application
        • 15.5.2.2.3. By Process Development
        • 15.5.2.2.4. By End User
    • 15.5.3. Italy Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By Application
        • 15.5.3.2.3. By Process Development
        • 15.5.3.2.4. By End User
    • 15.5.4. U.K. Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Product
        • 15.5.4.2.2. By Application
        • 15.5.4.2.3. By Process Development
        • 15.5.4.2.4. By End User
    • 15.5.5. Spain Market Analysis
      • 15.5.5.1. Introduction
      • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.5.2.1. By Product
        • 15.5.5.2.2. By Application
        • 15.5.5.2.3. By Process Development
        • 15.5.5.2.4. By End User
    • 15.5.6. Russia Market Analysis
      • 15.5.6.1. Introduction
      • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.6.2.1. By Product
        • 15.5.6.2.2. By Application
        • 15.5.6.2.3. By Process Development
        • 15.5.6.2.4. By End User
    • 15.5.7. Nordic Countries Market Analysis
      • 15.5.7.1. Introduction
      • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.7.2.1. By Product
        • 15.5.7.2.2. By Application
        • 15.5.7.2.3. By Process Development
        • 15.5.7.2.4. By End User
    • 15.5.8. BENELUX Market Analysis
      • 15.5.8.1. Introduction
      • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.8.2.1. By Product
        • 15.5.8.2.2. By Application
        • 15.5.8.2.3. By Process Development
        • 15.5.8.2.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Thailand
      • 16.3.1.3. Indonesia
      • 16.3.1.4. Malaysia
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Process Development
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By Process Development
    • 16.4.5. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. India Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Application
        • 16.5.1.2.3. By Process Development
        • 16.5.1.2.4. By End User
    • 16.5.2. Thailand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Application
        • 16.5.2.2.3. By Process Development
        • 16.5.2.2.4. By End User
    • 16.5.3. Indonesia Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Product
        • 16.5.3.2.2. By Application
        • 16.5.3.2.3. By Process Development
        • 16.5.3.2.4. By End User
    • 16.5.4. Malaysia Market Analysis
      • 16.5.4.1. Introduction
      • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.4.2.1. By Product
        • 16.5.4.2.2. By Application
        • 16.5.4.2.3. By Process Development
        • 16.5.4.2.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By Process Development
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By Process Development
    • 17.4.5. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. China Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Application
        • 17.5.1.2.3. By Process Development
        • 17.5.1.2.4. By End User
    • 17.5.2. Japan Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Application
        • 17.5.2.2.3. By Process Development
        • 17.5.2.2.4. By End User
    • 17.5.3. South Korea Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Application
        • 17.5.3.2.3. By Process Development
        • 17.5.3.2.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Application
    • 18.3.4. By Process Development
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Application
    • 18.4.4. By Process Development
    • 18.4.5. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. Australia Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Product
        • 18.5.1.2.2. By Application
        • 18.5.1.2.3. By Process Development
        • 18.5.1.2.4. By End User
    • 18.5.2. New Zealand Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Product
        • 18.5.2.2.2. By Application
        • 18.5.2.2.3. By Process Development
        • 18.5.2.2.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. Northern Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Application
    • 19.3.4. By Process Development
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Application
    • 19.4.4. By Process Development
    • 19.4.5. By End User
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. GCC Countries Market Analysis
      • 19.5.1.1. Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Product
        • 19.5.1.2.2. By Application
        • 19.5.1.2.3. By Process Development
        • 19.5.1.2.4. By End User
    • 19.5.2. Turkiye Market Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Product
        • 19.5.2.2.2. By Application
        • 19.5.2.2.3. By Process Development
        • 19.5.2.2.4. By End User
    • 19.5.3. Northern Africa Market Analysis
      • 19.5.3.1. Introduction
      • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.3.2.1. By Product
        • 19.5.3.2.2. By Application
        • 19.5.3.2.3. By Process Development
        • 19.5.3.2.4. By End User
    • 19.5.4. South Africa Market Analysis
      • 19.5.4.1. Introduction
      • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.4.2.1. By Product
        • 19.5.4.2.2. By Application
        • 19.5.4.2.3. By Process Development
        • 19.5.4.2.4. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. GE Healthcare
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
        • 21.3.1.5.1. Marketing Strategy
        • 21.3.1.5.2. Product Strategy
        • 21.3.1.5.3. Channel Strategy
    • 21.3.2. Merck KgAa
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Key Financials
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
        • 21.3.2.5.1. Marketing Strategy
        • 21.3.2.5.2. Product Strategy
        • 21.3.2.5.3. Channel Strategy
    • 21.3.3. Danaher Corporation
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Key Financials
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
        • 21.3.3.5.1. Marketing Strategy
        • 21.3.3.5.2. Product Strategy
        • 21.3.3.5.3. Channel Strategy
    • 21.3.4. Thermo Fisher Scientific Inc.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Key Financials
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
        • 21.3.4.5.1. Marketing Strategy
        • 21.3.4.5.2. Product Strategy
        • 21.3.4.5.3. Channel Strategy
    • 21.3.5. Bio Rad Laboratories Inc.
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Key Financials
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
        • 21.3.5.5.1. Marketing Strategy
        • 21.3.5.5.2. Product Strategy
        • 21.3.5.5.3. Channel Strategy
    • 21.3.6. Sartorius AG
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Key Financials
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
        • 21.3.6.5.1. Marketing Strategy
        • 21.3.6.5.2. Product Strategy
        • 21.3.6.5.3. Channel Strategy
    • 21.3.7. Agilent Technologies
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Key Financials
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
        • 21.3.7.5.1. Marketing Strategy
        • 21.3.7.5.2. Product Strategy
        • 21.3.7.5.3. Channel Strategy
    • 21.3.8. Luminex Applikon
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Key Financials
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
        • 21.3.8.5.1. Marketing Strategy
        • 21.3.8.5.2. Product Strategy
        • 21.3.8.5.3. Channel Strategy
    • 21.3.9. Tecan Trading AG
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Key Financials
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
        • 21.3.9.5.1. Marketing Strategy
        • 21.3.9.5.2. Product Strategy
        • 21.3.9.5.3. Channel Strategy
    • 21.3.10. Eppendorf AG
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Key Financials
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
        • 21.3.10.5.1. Marketing Strategy
        • 21.3.10.5.2. Product Strategy
        • 21.3.10.5.3. Channel Strategy
    • 21.3.11. PerkinElmer Inc.
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Key Financials
      • 21.3.11.4. Sales Footprint
      • 21.3.11.5. Strategy Overview
        • 21.3.11.5.1. Marketing Strategy
        • 21.3.11.5.2. Product Strategy
        • 21.3.11.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology